Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Capital Reinvestment Ratio
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥281.88 Million) in capital expenditures (CN¥54.40 Million). Check Shaanxi Meibang Pharmaceutical Group Co tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shaanxi Meibang Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2017–2024)
This chart tracks Shaanxi Meibang Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Shaanxi Meibang Pharmaceutical Group Co (605033) cash conversion ratio.
Annual Capital Reinvestment Ratio for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year Capital Reinvestment Ratio for Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024. See Shaanxi Meibang Pharmaceutical Group Co free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.57x | CN¥280.40 Million | CN¥158.81 Million | ▼ -6.9% |
| 2023 | 0.61x | CN¥334.79 Million | CN¥203.69 Million | ▼ -29.6% |
| 2022 | 0.86x | CN¥126.41 Million | CN¥109.29 Million | ▲ +4.9% |
| 2020 | 0.82x | CN¥74.88 Million | CN¥61.71 Million | ▲ +213.4% |
| 2019 | 0.26x | CN¥128.45 Million | CN¥33.78 Million | ▼ -87.2% |
| 2018 | 2.06x | CN¥16.96 Million | CN¥34.86 Million | ▲ +244.2% |
| 2017 | 0.60x | CN¥29.41 Million | CN¥17.56 Million | — |